| Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
Is a |
Neoplasm observable |
true |
Inferred relationship |
Some |
|
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute specifies the independent continuant which bears the quality, and on which the dependent quality (of this observable) depends. |
Malignant neoplasm (morphologic abnormality) |
false |
Inferred relationship |
Some |
4 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute is used to specify the type of inherent quality, function, disposition or process characteristic that is being observed or measured. Its values are abstract types of quality (length, odor, concentration) or abstract types of process characteristic (rate, speed, duration), and do not include qualities that are located (length of arm, odor of urine), or given a value (elevated concentration). |
Percent |
false |
Inferred relationship |
Some |
1 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute refers to the scale of the result of an observation or a diagnostic test. |
Quantitative value |
false |
Inferred relationship |
Some |
2 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute specifies the process which the property describes, and on which the property (of this observable) depends. The process can be very general. |
Malignant proliferation of primary neoplasm (qualifier value) |
false |
Inferred relationship |
Some |
5 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute specifies the process which the property describes, and on which the property (of this observable) depends. The process can be very general. |
Regression of neoplasm (qualifier value) |
false |
Inferred relationship |
Some |
6 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute is used to specify body state, timing, challenges, and other situations that must be true of the entity to be observed. |
Neoadjuvant antineoplastic therapy (procedure) |
false |
Inferred relationship |
Some |
7 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
Time aspect (attribute) |
Single point in time |
false |
Inferred relationship |
Some |
3 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute specifies the independent continuant which bears the quality, and on which the dependent quality (of this observable) depends. |
Malignant neoplasm (morphologic abnormality) |
true |
Inferred relationship |
Some |
1 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute refers to the scale of the result of an observation or a diagnostic test. |
Quantitative value |
true |
Inferred relationship |
Some |
1 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute specifies the process which the property describes, and on which the property (of this observable) depends. The process can be very general. |
Malignant proliferation of primary neoplasm (qualifier value) |
true |
Inferred relationship |
Some |
1 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute specifies the process which the property describes, and on which the property (of this observable) depends. The process can be very general. |
Regression of neoplasm (qualifier value) |
true |
Inferred relationship |
Some |
1 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute is used to specify body state, timing, challenges, and other situations that must be true of the entity to be observed. |
Neoadjuvant antineoplastic therapy (procedure) |
true |
Inferred relationship |
Some |
1 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
Time aspect (attribute) |
Single point in time |
true |
Inferred relationship |
Some |
1 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute is used to specify the type of inherent quality, function, disposition or process characteristic that is being observed or measured. Its values are abstract types of quality (length, odor, concentration) or abstract types of process characteristic (rate, speed, duration), and do not include qualities that are located (length of arm, odor of urine), or given a value (elevated concentration). |
Quantity fraction |
true |
Inferred relationship |
Some |
1 |
|
| Percent viable malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity) |
This attribute represents the units used in assigning a value to an observation. |
Percentage unit (qualifier value) |
true |
Inferred relationship |
Some |
1 |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]